Revs up overnight metabolism to burn fat as you rest
Subsequently, a new generation of GLP-based drugs emerged that lasted even longer
Last reviewed: May 15, 2026 Last updated: May 15, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Antibody blockade of activin type II receptors preserves skeletal muscle mass and enhances fat loss during GLP-1 receptor agonism
was supported by a Universit Paris Cit IdEx PhD Fellowship and a EUR GENE, G.E.N.E
If you are undergoing a particular FBC investigation and need these specific markers for your GP, we advise you to come to one of our clinics for a venous sample